BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20816276)

  • 1. Management of diffuse low-grade cerebral gliomas.
    Prabhu VC; Khaldi A; Barton KP; Melian E; Schneck MJ; Primeau MJ; Lee JM
    Neurol Clin; 2010 Nov; 28(4):1037-59. PubMed ID: 20816276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Controversial aspects in WHO grade II gliomas management: review of recent literature].
    Rueda E; Sierra M; Infante J; Berciano J; Vázquez-Barquero A; Ciordia R; Martino J
    Rev Neurol; 2011 Dec; 53(12):747-57. PubMed ID: 22127662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of low-grade gliomas].
    Duffau H
    Rev Prat; 2006 Oct; 56(16):1771-7. PubMed ID: 17315502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary brain tumors in adults.
    Chandana SR; Movva S; Arora M; Singh T
    Am Fam Physician; 2008 May; 77(10):1423-30. PubMed ID: 18533376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathological and molecular aspects of low-grade and high-grade gliomas.
    Michotte A; Neyns B; Chaskis C; Sadones J; In 't Veld P
    Acta Neurol Belg; 2004 Dec; 104(4):148-53. PubMed ID: 15742604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment modalities for malignant gliomas with reference to their pathophysiology].
    Kobayashi S; Takakura K
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):11-7. PubMed ID: 3942392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-grade glioma on stereotactic biopsy: how often is the diagnosis accurate?
    Muragaki Y; Chernov M; Maruyama T; Ochiai T; Taira T; Kubo O; Nakamura R; Iseki H; Hori T; Takakura K
    Minim Invasive Neurosurg; 2008 Oct; 51(5):275-9. PubMed ID: 18855292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse WHO grade 2 gliomas treated without chemotherapy.
    Mariani L; Deiana G; Vassella E; Fathi AR; Murtin C; Arnold M; Vajtai I; Weis J; Siegenthaler P; Schobesberger M; Reinert MM
    J Clin Oncol; 2006 Oct; 24(29):4758-63. PubMed ID: 16966689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding high grade glioma: molecular mechanism, therapy and comprehensive management.
    Wang Y; Jiang T
    Cancer Lett; 2013 May; 331(2):139-46. PubMed ID: 23340179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945.
    Fouladi M; Hunt DL; Pollack IF; Dueckers G; Burger PC; Becker LE; Yates AJ; Gilles FH; Davis RL; Boyett JM; Finlay JL
    Cancer; 2003 Sep; 98(6):1243-52. PubMed ID: 12973849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
    Gnekow AK; Kortmann RD; Pietsch T; Emser A
    Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy for low-grade gliomas.
    Paleologos NA
    Expert Rev Neurother; 2005 Nov; 5(6 Suppl):S21-4. PubMed ID: 16274267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II: Treatment-related late toxicity.
    Kortmann RD; Timmermann B; Taylor RE; Scarzello G; Plasswilm L; Paulsen F; Jeremic B; Gnekow AK; Dieckmann K; Kay S; Bamberg M
    Strahlenther Onkol; 2003 Sep; 179(9):585-97. PubMed ID: 14628124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brainstem gliomas.
    Packer RJ; Nicholson HS; Vezina LG; Johnson DL
    Neurosurg Clin N Am; 1992 Oct; 3(4):863-79. PubMed ID: 1392581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
    Hargrave D
    Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of tectal glioma in childhood.
    Stark AM; Fritsch MJ; Claviez A; Dörner L; Mehdorn HM
    Pediatr Neurol; 2005 Jul; 33(1):33-8. PubMed ID: 15876519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-grade gliomas in adults.
    Grier JT; Batchelor T
    Oncologist; 2006 Jun; 11(6):681-93. PubMed ID: 16794247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biology and treatment of malignant glioma.
    Prados MD; Levin V
    Semin Oncol; 2000 Jun; 27(3 Suppl 6):1-10. PubMed ID: 10866344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. World Health Organization Grade II gliomas and subventricular zone: anatomic, genetic, and clinical considerations.
    Vergani F; Martino J; Gozé C; Rigau V; Duffau H
    Neurosurgery; 2011 May; 68(5):1293-8; discussion 1298-9. PubMed ID: 21273932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric high-grade gliomas and diffuse intrinsic pontine gliomas.
    Fangusaro J
    J Child Neurol; 2009 Nov; 24(11):1409-17. PubMed ID: 19638636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.